Relationship between respiratory microbiome and systemic inflammatory markers in COPD: A pilot study

Casadevall Fusté, Carme; Quero, Sara; Millares, Laura; Faner, Rosa; Cosío, Borja G.; Peces-Barba Romero, Germán; Castro-Acosta, Ady Angélica; Montón, Concepción; Palou, Alexandre; Pascual Guàrdia, Sergi, 1979-; Agustí García-Navarro, Àlvar; Gea Guiral, Joaquim; Monsó Molas, Eduard; BIOMEPOC group

doi:http://dx.doi.org/10.3390/ijms25158467

Relationship between respiratory microbiome and systemic inflammatory markers in COPD: A pilot study

Llicència

Citació

Casadevall C, Quero S, Millares L, Faner R, Cosío BG, Peces-Barba G, et al. Relationship between respiratory microbiome and systemic inflammatory markers in COPD: A pilot study. Int J Mol Sci. 2024 Aug 2;25(15):8467. DOI: 10.3390/ijms25158467

Resum

The respiratory microbiome may influence the development and progression of COPD by modulating local immune and inflammatory events. We aimed to investigate whether relative changes in respiratory bacterial abundance are also associated with systemic inflammation, and explore their relationship with the main clinical COPD phenotypes. Multiplex analysis of inflammatory markers and transcript eosinophil-related markers were analyzed on peripheral blood in a cohort of stable COPD patients (n = 72). Respiratory microbiome composition was analyzed by 16S rRNA microbial sequencing on spontaneous sputum. Spearman correlations were applied to test the relationship between the microbiome composition and systemic inflammation. The concentration of the plasma IL-8 showed an inverted correlation with the relative abundance of 17 bacterial genera in the whole COPD cohort. COPD patients categorized as eosinophilic showed positive relationships with blood eosinophil markers and inversely correlated with the degree of airway obstruction and the number of exacerbations during the previous year. COPD patients categorized as frequent exacerbators were enriched with the bacterial genera Pseudomonas which, in turn, was positively associated with the severity of airflow limitation and the prior year's exacerbation history. The associative relationships of the sputum microbiome with the severity of the disease emphasize the relevance of the interaction between the respiratory microbiota and systemic inflammation.